Chill Brands Group (CHLL) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock CHLL vs. PXS, MXC, RGT, CEL, N4P, HELD, BXP, HLN, HIK, and HCMShould you be buying Chill Brands Group stock or one of its competitors? The main competitors of Chill Brands Group include Provexis (PXS), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Hellenic Dynamics (HELD), Beximco Pharmaceuticals (BXP), Haleon (HLN), Hikma Pharmaceuticals (HIK), and HUTCHMED (HCM). These companies are all part of the "drug manufacturers - specialty & generic" industry. Chill Brands Group vs. Its Competitors Provexis Argent BioPharma Argent BioPharma Celadon Pharmaceuticals N4 Pharma Hellenic Dynamics Beximco Pharmaceuticals Haleon Hikma Pharmaceuticals HUTCHMED Chill Brands Group (LON:CHLL) and Provexis (LON:PXS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation. Does the media favor CHLL or PXS? In the previous week, Chill Brands Group's average media sentiment score of 0.00 equaled Provexis'average media sentiment score. Company Overall Sentiment Chill Brands Group Neutral Provexis Neutral Which has higher valuation & earnings, CHLL or PXS? Provexis has higher revenue and earnings than Chill Brands Group. Provexis is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChill Brands Group£624.19K0.00-£3.64M-£0.01N/AProvexis£846.98K19.56-£619.15K-£0.03-26.77 Is CHLL or PXS more profitable? Chill Brands Group has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Provexis' return on equity of -68.68% beat Chill Brands Group's return on equity.Company Net Margins Return on Equity Return on Assets Chill Brands GroupN/A -2,802.21% -44.64% Provexis -73.10%-68.68%-56.14% Do insiders and institutionals believe in CHLL or PXS? 0.2% of Chill Brands Group shares are owned by institutional investors. Comparatively, 7.9% of Provexis shares are owned by institutional investors. 24.2% of Chill Brands Group shares are owned by company insiders. Comparatively, 21.6% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, CHLL or PXS? Chill Brands Group has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Provexis has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. SummaryProvexis beats Chill Brands Group on 6 of the 10 factors compared between the two stocks. Get Chill Brands Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHLL vs. The Competition Export to ExcelMetricChill Brands GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£8.38M£2.26B£5.81B£3.22BDividend YieldN/A2.92%4.40%5.04%P/E Ratio-165.504.3631.30164.70Price / SalesN/A691.66387.26310,111.42Price / Cash11.5010.3738.0227.93Price / BookN/A11.959.535.91Net Income-£3.64M£20.70B£3.26B£5.89B7 Day Performance12.36%1.07%2.13%49.52%1 Month PerformanceN/A3.82%3.21%56.91%1 Year PerformanceN/A4.37%30.18%140.38% Chill Brands Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHLLChill Brands GroupN/AN/AN/AN/A£8.38M£624.19K-165.507PXSProvexisN/AGBX 0.71-4.3%N/A+39.8%£16.57M£846.98K-26.774Gap DownMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255News CoverageGap UpRGTArgent BioPharmaN/AN/AN/AN/A£8.31MN/A-0.65N/AGap DownHigh Trading VolumeCELCeladon PharmaceuticalsN/AGBX 13.40flatN/AN/A£8.22M£123.38K-1.682,780N4PN4 PharmaN/AGBX 0.40-18.4%N/A-9.3%£1.72M£8.84K-1.165Gap UpHELDHellenic DynamicsN/AGBX 0.01flatN/AN/A£14KN/A0.00N/ABXPBeximco PharmaceuticalsN/AGBX 48.40+1.9%N/A+65.4%£32.99B£7.08T5.195,500Gap UpHLNHaleon0.9264 of 5 starsGBX 360.25+0.3%GBX 435+20.7%-1.8%£32.51B£11.07B30.3025,408High Trading VolumeHIKHikma Pharmaceuticals4.2308 of 5 starsGBX 1,805-0.3%GBX 2,627.50+45.6%-8.8%£5.01B£3.74B17.719,100News CoveragePositive NewsInsider TradeHCMHUTCHMEDN/AGBX 237.70+1.4%N/A-9.1%£2.58B£771.01M-60.671,760News Coverage Related Companies and Tools Related Companies PXS Alternatives MXC Alternatives RGT Alternatives CEL Alternatives N4P Alternatives HELD Alternatives BXP Alternatives HLN Alternatives HIK Alternatives HCM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CHLL) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chill Brands Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Chill Brands Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access